Latest Stock Split Details
Key information about Propanc Biopharma, Inc.'s most recent stock split
Split Date: 2026-05-18
Split Ratio: 1:25
Price Before Split: $0.08
Price After Split: $0.00
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 25.00 times fewer shares (a 1:25 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Propanc Biopharma, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2026-05-18 | 1:25 | Yes | $0.08 | $0.00 |
| 2025-01-29 | 1:60000 | Yes | $0.00 | $0.00 |
| 2023-05-23 | 1:1000 | Yes | $0.00 | $0.00 |
| 2020-11-19 | 1:1000 | Yes | $0.00 | $0.00 |
| 2019-06-24 | 1:500 | Yes | $0.00 | $0.00 |
| 2017-04-20 | 1:250 | Yes | $0.00 | $0.00 |
| 2017-04-07 | 1:250 | Yes | $0.00 | $0.00 |
About Propanc Biopharma, Inc.
Company overview and industry information
Propanc Biopharma, Inc. (PPCB) operates in the Biotechnology industry. The recent 1-for-25 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Propanc Biopharma, Inc. Summary